<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03069716</url>
  </required_header>
  <id_info>
    <org_study_id>IRB #162004</org_study_id>
    <nct_id>NCT03069716</nct_id>
  </id_info>
  <brief_title>A Mobile Health Intervention in Pulmonary Arterial Hypertension</brief_title>
  <acronym>mHealth</acronym>
  <official_title>A Mobile Health Intervention in Pulmonary Arterial Hypertension</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vanderbilt University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Vanderbilt University Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study proposes the use of a mobile health intervention (utilizing a smart phone app) to&#xD;
      encourage increased exercise in PAH patients. The study will be a randomized trial to examine&#xD;
      feasibility of an mHealth (mobile device) Fitbit Charge HR and cell phone application&#xD;
      intervention to improve step counts and increase participants activity level as compared to&#xD;
      no intervention. The Fitbit Charge Heart Rate (HR) monitors activity and the cell phone&#xD;
      application provides encouragement notifications to half the subjects while the other half do&#xD;
      not receive encouragements.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with pulmonary arterial hypertension (PAH) have severely reduced exercise capacity&#xD;
      and reduced quality of life. At diagnosis, most PAH patients are New York Heart Association&#xD;
      (NYHA) functional class III with symptoms of fatigue and shortness of breath with less than&#xD;
      ordinary activity. Physical activity confers multiple benefits relevant to PAH&#xD;
      pathophysiology including improvements in endothelial function, energy metabolism, and right&#xD;
      ventricular (RV) function. Increasing physical activity is highly efficacious in PAH,&#xD;
      resulting in six-minute walk distance (6MWD) improvement that exceeds the effect of&#xD;
      medications.&#xD;
&#xD;
      The goal of this proposal is to adapt and test the feasibility of our mHealth intervention to&#xD;
      increase physical activity in a geographically diverse PAH population. In secondary aims, we&#xD;
      will assess conventional PAH trial outcomes (6MWD, quality of life) and physiologic&#xD;
      mechanisms by which increasing activity may improve exercise capacity.&#xD;
&#xD;
      The investigator hypothesizes that an mHealth intervention is feasible and will increase&#xD;
      physical activity in subjects with PAH. This study proposes a randomized trial of unblinded&#xD;
      step tracking with smart texts tracking for 12 weeks. Participants will wear a display-free&#xD;
      triaxial accelerometer, which will continuously transmit data to a compatible smartphone&#xD;
      (owned by 75% of our PAH population). Efficacy endpoints have been selected to mirror FDA&#xD;
      criteria for drug approval in PAH. The following aims will be tested:&#xD;
&#xD;
      Aim 1: To test the feasibility of an mHealth intervention to increase step counts in patients&#xD;
      with PAH. Fifty PAH patients will be randomized to the mHealth intervention or usual activity&#xD;
      for 12 weeks. The primary endpoint will be daily step count during Week 12. Secondary&#xD;
      endpoints will assess step target achievement, daily activity time, and aerobic time. The&#xD;
      fidelity of data collection and text transmission will also be assessed.&#xD;
&#xD;
      Aim 2: To examine the effect of an mHealth intervention on exercise capacity and quality of&#xD;
      life. Participants will complete a six minute walk test and the emPHasis-10 questionnaire at&#xD;
      baseline and 12 weeks. The primary endpoint will be six minute walk distance. Secondary&#xD;
      endpoints will be emPHasis-10 quality of life scale score, Borg dyspnea score, and resting&#xD;
      heart rate.&#xD;
&#xD;
      Aim 3: To examine the effect of an mHealth intervention on mechanisms of improved exercise&#xD;
      capacity. Subjects will undergo echocardiography, blood draw, and body composition&#xD;
      assessment. The primary endpoint will be RV longitudinal strain. Secondary endpoints will be&#xD;
      the homeostatic model assessment of insulin resistance, lean muscle and fat mass, and B-type&#xD;
      natriuretic peptide.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 2, 2017</start_date>
  <completion_date type="Actual">April 24, 2020</completion_date>
  <primary_completion_date type="Actual">April 24, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomization will occur after a two-week run-in period to improve ability to identify a true baseline step count and account for potential dropout. Participants will be assigned to either the smartphone text messaging or no smartphone text messaging arms in a random manner until 25 participants are enrolled into each arm. Permuted block randomization stratified by functional class (I/II vs. III) will be used to ensure approximate balance of treatment groups within each stratum over time. Randomization will be performed in small blocks, which vary in size. Investigators will be unaware of the size or order of the blocks. Randomization will occur through REDCap by a study coordinator. Although the texting intervention will end after Week 12, subjects in both groups will be asked to continue wearing the Fitbit Charge HR device for an additional 3 weeks to determine whether withdrawal of the texting intervention results in a reduction in step counts.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>Investigators are blinded.&#xD;
Study personnel conducting 6MWT and echo will be blinded.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Daily Step Count</measure>
    <time_frame>Baseline to 12 weeks</time_frame>
    <description>Change from baseline mean daily step count at week 12.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Six Minute Walk Test Distance</measure>
    <time_frame>Baseline to 12 weeks</time_frame>
    <description>Change from baseline of six minute walk test distance (meters) at week 12.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Right Ventricle (RV) Strain</measure>
    <time_frame>Baseline to 12 weeks</time_frame>
    <description>Change from baseline of RV free wall longitudinal strain at week 12.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Days Participants Met Their Daily Step Count Goal</measure>
    <time_frame>Baseline to 12 weeks</time_frame>
    <description>All participants were provided with an Fitbit Charge Heart Rate mobile device to monitor daily step counts, activity time, and aerobic time. The daily goal was communicated via text to the intervention group and was the baseline step count average for the control group. Increased daily goal attainment indicates increased activity level</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Daily Aerobic Time</measure>
    <time_frame>Baseline to 12 weeks</time_frame>
    <description>Change in minutes of activity per day between Week 12 and Baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline at Week 12 in emPHasis-10 Questionnaire Score</measure>
    <time_frame>Baseline to 12 weeks</time_frame>
    <description>Quality of life was assessed using the emPHasis-10 questionnaire, a disease-specific self-administered 10-question questionnaire designed for routine assessment of health-related quality of life in pulmonary hypertension. Total score can range from 0 to 50, with higher scores indicating a worse quality of life. Change from Baseline was calculated as the value at Week 12 minus the value at Baseline. The Week 12 value was defined as the last assessment at or prior to Week 12.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline on the SF-36 Mental Component Summary (MCS) Score</measure>
    <time_frame>Baseline to 12 weeks</time_frame>
    <description>SF-36 consists of 36 questions measuring 8 health domains: physical functioning, bodily pain, role limitations due to physical problems, role limitations due to emotional problems, general health perceptions, mental health, social function, and vitality. The patient's responses are solicited using Likert scales that vary in length, with 3-6 response options per item. The SF-36 can be scored into the 8 health domains named above and two overall summary scores: physical component summary (PCS) and mental component summary (MCS) scores. The domain and summary scores range from 0 to 100; higher scores indicate better levels of function and/or better health</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline to Week 12 in Borg Dyspnea Score</measure>
    <time_frame>Baseline to 12 weeks</time_frame>
    <description>The Borg Dyspnea score is a self-rating scale to evaluate the severity of dyspnea (from 0 &quot;no shortness of breath at all&quot; to 10 &quot;very, very severe / maximal&quot; shortness of breath). The scale was completed at the beginning and conclusion of each 6-minute walk test at baseline and at Week 12. Median change from baseline in scoring was reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Resting Heart Rate</measure>
    <time_frame>Baseline to 12 weeks</time_frame>
    <description>Change in heart rate between Week 12 and Baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Lean Mass</measure>
    <time_frame>Baseline to 12 weeks</time_frame>
    <description>Change from baseline lean mass at week 12.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insulin Resistance</measure>
    <time_frame>Baseline to 12 weeks</time_frame>
    <description>Insulin resistance measured by the Homeostatic Model Assessment for Insulin Resistance insulin resistance score (HOMA-IR) utilizing the formula: fasting plasma glucose (mmol/l) times fasting serum insulin (mU/l) divided by 22.5. Low HOMA-IR values indicate high insulin sensitivity, whereas high HOMA-IR values indicate low insulin sensitivity (insulin resistance).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>BNP</measure>
    <time_frame>Baseline to 12 weeks</time_frame>
    <description>Change from baseline B-type natriuretic peptide level at week 12.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline on the SF-36 Physical Component Summary (PCS) Score</measure>
    <time_frame>Baseline to 12 weeks</time_frame>
    <description>SF-36 consists of 36 questions measuring 8 health domains: physical functioning, bodily pain, role limitations due to physical problems, role limitations due to emotional problems, general health perceptions, mental health, social function, and vitality. The patient's responses are solicited using Likert scales that vary in length, with 3-6 response options per item. The SF-36 can be scored into the 8 health domains named above and two overall summary scores: physical component summary (PCS) and mental component summary (MCS) scores. The domain and summary scores range from 0 to 100; higher scores indicate better levels of function and/or better health</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Minutes of Moderate-vigorous Activity</measure>
    <time_frame>Baseline to 12 Weeks</time_frame>
    <description>Change in minutes between Week 12 and Baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visceral Fat Volume</measure>
    <time_frame>Baseline to Week 12</time_frame>
    <description>Change in fat volume between Week 12 and Baseline</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">49</enrollment>
  <condition>Pulmonary Arterial Hypertension</condition>
  <condition>Idiopathic Pulmonary Arterial Hypertension</condition>
  <condition>Heritable Pulmonary Arterial Hypertension</condition>
  <condition>Associated Pulmonary Arterial Hypertension</condition>
  <arm_group>
    <arm_group_label>Smartphone Text Messaging</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group receives personalized, health coaching via &quot;smart&quot; text messages.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No Smartphone Text Messaging</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Group does not receive personalized, health coaching via &quot;smart&quot; text messages.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Smartphone Text Messaging</intervention_name>
    <description>A HIPPA compliant text messaging platform is linked to the Fitbit Application Program Interface. Real time activity data will be transmitted from the subject's smartphone to our mHealth platform via cellular network. Subjects will receive 3 texts/day in sync with their preferred morning, lunch, and evening leisure schedule (defined at enrollment). These texts will use personal, disease-specific, and provider information to deliver 2 types of messages customized to the current step count and sent in equal proportion. Messages are designed to facilitate self-awareness, reinforce step targets, and link physical activity with a reward or memorable cue.</description>
    <arm_group_label>Smartphone Text Messaging</arm_group_label>
    <other_name>mHealth activity intervention</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Fitbit Charge HR</intervention_name>
    <description>The Fitbit Charge HR tri-axial accelerometer will be used to continuously gather data on physical activity, heart rate, and sleep. This device provides feedback in units of activity (steps, stairs climbed, activity time, and exercise time) and heart rate (per second when active, per 5 seconds when inactive). It has been validated against research devices in free-living conditions and is relatively inexpensive.</description>
    <arm_group_label>No Smartphone Text Messaging</arm_group_label>
    <arm_group_label>Smartphone Text Messaging</arm_group_label>
    <other_name>Digital Activity Tracker</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Aged 18 or older.&#xD;
&#xD;
          2. Diagnosed with idiopathic, heritable, or associated (connective tissue disease, drugs,&#xD;
             or toxins) pulmonary arterial hypertension (PAH) according to World Health&#xD;
             Organization consensus recommendations.&#xD;
&#xD;
          3. Stable PAH-specific medication regimen for three months prior to enrollment. Subjects&#xD;
             with only a single diuretic adjustment in the prior three months will be included.&#xD;
&#xD;
          4. Subjects must own a Bluetooth capable modern smartphone capable of receiving and&#xD;
             sending text messages and an active data plan.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Prohibited from normal activity due to wheelchair bound status, bed bound status,&#xD;
             reliance on a cane/walker, activity-limiting angina, activity-limiting osteoarthritis,&#xD;
             or other condition.&#xD;
&#xD;
          2. Pregnancy.&#xD;
&#xD;
          3. Diagnosis of PAH etiology other than idiopathic, heritable, or associated.&#xD;
&#xD;
          4. Forced vital capacity &lt;70% predicted.&#xD;
&#xD;
          5. Functional class IV heart failure.&#xD;
&#xD;
          6. Requirement of &gt; 1 diuretic adjustment in the prior three months.&#xD;
&#xD;
          7. Preferred form of activity is not measured by an activity tracker (swimming, yoga, ice&#xD;
             skating, stair master, or activities on wheels such as bicycling or rollerblading).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Evan Brittain, MD, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vanderbilt University Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Martin SS, Feldman DI, Blumenthal RS, Jones SR, Post WS, McKibben RA, Michos ED, Ndumele CE, Ratchford EV, Coresh J, Blaha MJ. mActive: A Randomized Clinical Trial of an Automated mHealth Intervention for Physical Activity Promotion. J Am Heart Assoc. 2015 Nov 9;4(11). pii: e002239. doi: 10.1161/JAHA.115.002239.</citation>
    <PMID>26553211</PMID>
  </reference>
  <reference>
    <citation>Pugh ME, Buchowski MS, Robbins IM, Newman JH, Hemnes AR. Physical activity limitation as measured by accelerometry in pulmonary arterial hypertension. Chest. 2012 Dec;142(6):1391-1398. doi: 10.1378/chest.12-0150.</citation>
    <PMID>22576635</PMID>
  </reference>
  <reference>
    <citation>Bravata DM, Smith-Spangler C, Sundaram V, Gienger AL, Lin N, Lewis R, Stave CD, Olkin I, Sirard JR. Using pedometers to increase physical activity and improve health: a systematic review. JAMA. 2007 Nov 21;298(19):2296-304. Review.</citation>
    <PMID>18029834</PMID>
  </reference>
  <reference>
    <citation>Mereles D, Ehlken N, Kreuscher S, Ghofrani S, Hoeper MM, Halank M, Meyer FJ, Karger G, Buss J, Juenger J, Holzapfel N, Opitz C, Winkler J, Herth FF, Wilkens H, Katus HA, Olschewski H, Gr√ºnig E. Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation. 2006 Oct 3;114(14):1482-9. Epub 2006 Sep 18.</citation>
    <PMID>16982941</PMID>
  </reference>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>February 21, 2017</study_first_submitted>
  <study_first_submitted_qc>February 27, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 3, 2017</study_first_posted>
  <results_first_submitted>April 20, 2021</results_first_submitted>
  <results_first_submitted_qc>June 22, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">June 24, 2021</results_first_posted>
  <last_update_submitted>June 23, 2021</last_update_submitted>
  <last_update_submitted_qc>June 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vanderbilt University Medical Center</investigator_affiliation>
    <investigator_full_name>Evan Brittain</investigator_full_name>
    <investigator_title>Assistant Professor of Medicine</investigator_title>
  </responsible_party>
  <keyword>Pulmonary Arterial Hypertension</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pulmonary Arterial Hypertension</mesh_term>
    <mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>August 6, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/16/NCT03069716/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>After participant is enrolled, they are given a fitbit device to wear for a 14 day run-in period leading up to the baseline visit. After the baseline visit is completed they are then randomized.&#xD;
Reasons why a participants may have been removed from study prior to randomization include the participant dropping out for personal or medical issues.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Run-in Participants</title>
          <description>participant is enrolled, they are given a fitbit device to wear for a 14 day run-in period leading up to the baseline visit.</description>
        </group>
        <group group_id="P2">
          <title>Smartphone Text Messaging</title>
          <description>Group receives personalized, health coaching via &quot;smart&quot; text messages.&#xD;
Smartphone Text Messaging: A HIPPA compliant text messaging platform is linked to the Fitbit Application Program Interface. Real time activity data will be transmitted from the subject's smartphone to our mHealth platform via cellular network. Subjects will receive 3 texts/day in sync with their preferred morning, lunch, and evening leisure schedule (defined at enrollment). These texts will use personal, disease-specific, and provider information to deliver 2 types of messages customized to the current step count and sent in equal proportion. Messages are designed to facilitate self-awareness, reinforce step targets, and link physical activity with a reward or memorable cue.&#xD;
Fitbit Charge HR: The Fitbit Charge HR tri-axial accelerometer will be used to continuously gather data on physical activity, heart rate, and sleep. This device provides feedback in units of activity (steps, stairs climbed, activity time, and exercise time) and heart rate (per second when active, per 5 seconds when inactive). It has been validated against research devices in free-living conditions and is relatively inexpensive.</description>
        </group>
        <group group_id="P3">
          <title>No Smartphone Text Messaging</title>
          <description>Group does not receive personalized, health coaching via &quot;smart&quot; text messages.&#xD;
Fitbit Charge HR: The Fitbit Charge HR tri-axial accelerometer will be used to continuously gather data on physical activity, heart rate, and sleep. This device provides feedback in units of activity (steps, stairs climbed, activity time, and exercise time) and heart rate (per second when active, per 5 seconds when inactive). It has been validated against research devices in free-living conditions and is relatively inexpensive.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Run-in Period (2 Weeks)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="49"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="42"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Randomized Treatment</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="20"/>
                <participants group_id="P3" count="22"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="18"/>
                <participants group_id="P3" count="22"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Smartphone Text Messaging</title>
          <description>Group receives personalized, health coaching via &quot;smart&quot; text messages.&#xD;
Smartphone Text Messaging: A HIPPA compliant text messaging platform is linked to the Fitbit Application Program Interface. Real time activity data will be transmitted from the subject's smartphone to our mHealth platform via cellular network. Subjects will receive 3 texts/day in sync with their preferred morning, lunch, and evening leisure schedule (defined at enrollment). These texts will use personal, disease-specific, and provider information to deliver 2 types of messages customized to the current step count and sent in equal proportion. Messages are designed to facilitate self-awareness, reinforce step targets, and link physical activity with a reward or memorable cue.&#xD;
Fitbit Charge HR: The Fitbit Charge HR tri-axial accelerometer will be used to continuously gather data on physical activity, heart rate, and sleep. This device provides feedback in units of activity (steps, stairs climbed, activity time, and exercise time) and heart rate (per second when active, per 5 seconds when inactive). It has been validated against research devices in free-living conditions and is relatively inexpensive.</description>
        </group>
        <group group_id="B2">
          <title>No Smartphone Text Messaging</title>
          <description>Group does not receive personalized, health coaching via &quot;smart&quot; text messages.&#xD;
Fitbit Charge HR: The Fitbit Charge HR tri-axial accelerometer will be used to continuously gather data on physical activity, heart rate, and sleep. This device provides feedback in units of activity (steps, stairs climbed, activity time, and exercise time) and heart rate (per second when active, per 5 seconds when inactive). It has been validated against research devices in free-living conditions and is relatively inexpensive.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="20"/>
            <count group_id="B2" value="22"/>
            <count group_id="B3" value="42"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="47" lower_limit="41" upper_limit="54"/>
                    <measurement group_id="B2" value="47" lower_limit="36" upper_limit="58"/>
                    <measurement group_id="B3" value="47" lower_limit="39" upper_limit="57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="36"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="19"/>
                    <measurement group_id="B3" value="32"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Daily Step Count</title>
        <description>Change from baseline mean daily step count at week 12.</description>
        <time_frame>Baseline to 12 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Smartphone Text Messaging</title>
            <description>Group receives personalized, health coaching via &quot;smart&quot; text messages.&#xD;
Smartphone Text Messaging: A HIPPA compliant text messaging platform is linked to the Fitbit Application Program Interface. Real time activity data will be transmitted from the subject's smartphone to our mHealth platform via cellular network. Subjects will receive 3 texts/day in sync with their preferred morning, lunch, and evening leisure schedule (defined at enrollment). These texts will use personal, disease-specific, and provider information to deliver 2 types of messages customized to the current step count and sent in equal proportion. Messages are designed to facilitate self-awareness, reinforce step targets, and link physical activity with a reward or memorable cue.</description>
          </group>
          <group group_id="O2">
            <title>No Smartphone Text Messaging</title>
            <description>Group does not receive personalized, health coaching via &quot;smart&quot; text messages.</description>
          </group>
        </group_list>
        <measure>
          <title>Daily Step Count</title>
          <description>Change from baseline mean daily step count at week 12.</description>
          <units>Steps</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1409" lower_limit="-32" upper_limit="2220"/>
                    <measurement group_id="O2" value="-149" lower_limit="-1010" upper_limit="735"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Six Minute Walk Test Distance</title>
        <description>Change from baseline of six minute walk test distance (meters) at week 12.</description>
        <time_frame>Baseline to 12 weeks</time_frame>
        <population>Only 17 participants in the Smartphone Text Messaging arm were analyzed due to research shut downs during COVID. Any assessments requiring an in-person visit were not completed for one participant.</population>
        <group_list>
          <group group_id="O1">
            <title>Smartphone Text Messaging</title>
            <description>Group receives personalized, health coaching via &quot;smart&quot; text messages.&#xD;
Smartphone Text Messaging: A HIPPA compliant text messaging platform is linked to the Fitbit Application Program Interface. Real time activity data will be transmitted from the subject's smartphone to our mHealth platform via cellular network. Subjects will receive 3 texts/day in sync with their preferred morning, lunch, and evening leisure schedule (defined at enrollment). These texts will use personal, disease-specific, and provider information to deliver 2 types of messages customized to the current step count and sent in equal proportion. Messages are designed to facilitate self-awareness, reinforce step targets, and link physical activity with a reward or memorable cue.</description>
          </group>
          <group group_id="O2">
            <title>No Smartphone Text Messaging</title>
            <description>Group does not receive personalized, health coaching via &quot;smart&quot; text messages.</description>
          </group>
        </group_list>
        <measure>
          <title>Six Minute Walk Test Distance</title>
          <description>Change from baseline of six minute walk test distance (meters) at week 12.</description>
          <population>Only 17 participants in the Smartphone Text Messaging arm were analyzed due to research shut downs during COVID. Any assessments requiring an in-person visit were not completed for one participant.</population>
          <units>meters</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3" lower_limit="-42" upper_limit="23"/>
                    <measurement group_id="O2" value="-6" lower_limit="-36" upper_limit="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Right Ventricle (RV) Strain</title>
        <description>Change from baseline of RV free wall longitudinal strain at week 12.</description>
        <time_frame>Baseline to 12 weeks</time_frame>
        <population>Only 17 participants in the Smartphone Text Messaging arm were analyzed due to research shut downs during COVID. Any assessments requiring an in-person visit were not completed for one participant.</population>
        <group_list>
          <group group_id="O1">
            <title>Smartphone Text Messaging</title>
            <description>Group receives personalized, health coaching via &quot;smart&quot; text messages.&#xD;
Smartphone Text Messaging: A HIPPA compliant text messaging platform is linked to the Fitbit Application Program Interface. Real time activity data will be transmitted from the subject's smartphone to our mHealth platform via cellular network. Subjects will receive 3 texts/day in sync with their preferred morning, lunch, and evening leisure schedule (defined at enrollment). These texts will use personal, disease-specific, and provider information to deliver 2 types of messages customized to the current step count and sent in equal proportion. Messages are designed to facilitate self-awareness, reinforce step targets, and link physical activity with a reward or memorable cue.</description>
          </group>
          <group group_id="O2">
            <title>No Smartphone Text Messaging</title>
            <description>Group does not receive personalized, health coaching via &quot;smart&quot; text messages.</description>
          </group>
        </group_list>
        <measure>
          <title>Right Ventricle (RV) Strain</title>
          <description>Change from baseline of RV free wall longitudinal strain at week 12.</description>
          <population>Only 17 participants in the Smartphone Text Messaging arm were analyzed due to research shut downs during COVID. Any assessments requiring an in-person visit were not completed for one participant.</population>
          <units>percentage of deformation</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.1" lower_limit="-1.6" upper_limit="2.0"/>
                    <measurement group_id="O2" value="0.4" lower_limit="-1.9" upper_limit="1.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Days Participants Met Their Daily Step Count Goal</title>
        <description>All participants were provided with an Fitbit Charge Heart Rate mobile device to monitor daily step counts, activity time, and aerobic time. The daily goal was communicated via text to the intervention group and was the baseline step count average for the control group. Increased daily goal attainment indicates increased activity level</description>
        <time_frame>Baseline to 12 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Smartphone Text Messaging</title>
            <description>Group receives personalized, health coaching via &quot;smart&quot; text messages.</description>
          </group>
          <group group_id="O2">
            <title>No Smartphone Text Messaging</title>
            <description>Group does not receive personalized, health coaching via &quot;smart&quot; text messages.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Days Participants Met Their Daily Step Count Goal</title>
          <description>All participants were provided with an Fitbit Charge Heart Rate mobile device to monitor daily step counts, activity time, and aerobic time. The daily goal was communicated via text to the intervention group and was the baseline step count average for the control group. Increased daily goal attainment indicates increased activity level</description>
          <units>percent of days at goal across group</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="41"/>
                    <measurement group_id="O2" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Daily Aerobic Time</title>
        <description>Change in minutes of activity per day between Week 12 and Baseline</description>
        <time_frame>Baseline to 12 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Smartphone Text Messaging</title>
            <description>Group receives personalized, health coaching via &quot;smart&quot; text messages.</description>
          </group>
          <group group_id="O2">
            <title>No Smartphone Text Messaging</title>
            <description>Group does not receive personalized, health coaching via &quot;smart&quot; text messages.</description>
          </group>
        </group_list>
        <measure>
          <title>Daily Aerobic Time</title>
          <description>Change in minutes of activity per day between Week 12 and Baseline</description>
          <units>minutes</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10" lower_limit="-36" upper_limit="58"/>
                    <measurement group_id="O2" value="-16" lower_limit="-44" upper_limit="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline at Week 12 in emPHasis-10 Questionnaire Score</title>
        <description>Quality of life was assessed using the emPHasis-10 questionnaire, a disease-specific self-administered 10-question questionnaire designed for routine assessment of health-related quality of life in pulmonary hypertension. Total score can range from 0 to 50, with higher scores indicating a worse quality of life. Change from Baseline was calculated as the value at Week 12 minus the value at Baseline. The Week 12 value was defined as the last assessment at or prior to Week 12.</description>
        <time_frame>Baseline to 12 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Smartphone Text Messaging</title>
            <description>Group receives personalized, health coaching via &quot;smart&quot; text messages.</description>
          </group>
          <group group_id="O2">
            <title>No Smartphone Text Messaging</title>
            <description>Group does not receive personalized, health coaching via &quot;smart&quot; text messages.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline at Week 12 in emPHasis-10 Questionnaire Score</title>
          <description>Quality of life was assessed using the emPHasis-10 questionnaire, a disease-specific self-administered 10-question questionnaire designed for routine assessment of health-related quality of life in pulmonary hypertension. Total score can range from 0 to 50, with higher scores indicating a worse quality of life. Change from Baseline was calculated as the value at Week 12 minus the value at Baseline. The Week 12 value was defined as the last assessment at or prior to Week 12.</description>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3" lower_limit="-4.8" upper_limit="3.0"/>
                    <measurement group_id="O2" value="1.0" lower_limit="-2.0" upper_limit="3.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline on the SF-36 Mental Component Summary (MCS) Score</title>
        <description>SF-36 consists of 36 questions measuring 8 health domains: physical functioning, bodily pain, role limitations due to physical problems, role limitations due to emotional problems, general health perceptions, mental health, social function, and vitality. The patient's responses are solicited using Likert scales that vary in length, with 3-6 response options per item. The SF-36 can be scored into the 8 health domains named above and two overall summary scores: physical component summary (PCS) and mental component summary (MCS) scores. The domain and summary scores range from 0 to 100; higher scores indicate better levels of function and/or better health</description>
        <time_frame>Baseline to 12 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Smartphone Text Messaging</title>
            <description>Group receives personalized, health coaching via &quot;smart&quot; text messages.</description>
          </group>
          <group group_id="O2">
            <title>No Smartphone Text Messaging</title>
            <description>Group does not receive personalized, health coaching via &quot;smart&quot; text messages.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline on the SF-36 Mental Component Summary (MCS) Score</title>
          <description>SF-36 consists of 36 questions measuring 8 health domains: physical functioning, bodily pain, role limitations due to physical problems, role limitations due to emotional problems, general health perceptions, mental health, social function, and vitality. The patient's responses are solicited using Likert scales that vary in length, with 3-6 response options per item. The SF-36 can be scored into the 8 health domains named above and two overall summary scores: physical component summary (PCS) and mental component summary (MCS) scores. The domain and summary scores range from 0 to 100; higher scores indicate better levels of function and/or better health</description>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.8" lower_limit="0.9" upper_limit="8.7"/>
                    <measurement group_id="O2" value="1.5" lower_limit="-9.3" upper_limit="3.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline to Week 12 in Borg Dyspnea Score</title>
        <description>The Borg Dyspnea score is a self-rating scale to evaluate the severity of dyspnea (from 0 &quot;no shortness of breath at all&quot; to 10 &quot;very, very severe / maximal&quot; shortness of breath). The scale was completed at the beginning and conclusion of each 6-minute walk test at baseline and at Week 12. Median change from baseline in scoring was reported.</description>
        <time_frame>Baseline to 12 weeks</time_frame>
        <population>Only 17 participants in the Smartphone Text Messaging arm were analyzed due to research shut downs during COVID. Any assessments requiring an in-person visit were not completed for one participant.</population>
        <group_list>
          <group group_id="O1">
            <title>Smartphone Text Messaging</title>
            <description>Group receives personalized, health coaching via &quot;smart&quot; text messages.</description>
          </group>
          <group group_id="O2">
            <title>No Smartphone Text Messaging</title>
            <description>Group does not receive personalized, health coaching via &quot;smart&quot; text messages.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline to Week 12 in Borg Dyspnea Score</title>
          <description>The Borg Dyspnea score is a self-rating scale to evaluate the severity of dyspnea (from 0 &quot;no shortness of breath at all&quot; to 10 &quot;very, very severe / maximal&quot; shortness of breath). The scale was completed at the beginning and conclusion of each 6-minute walk test at baseline and at Week 12. Median change from baseline in scoring was reported.</description>
          <population>Only 17 participants in the Smartphone Text Messaging arm were analyzed due to research shut downs during COVID. Any assessments requiring an in-person visit were not completed for one participant.</population>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.0" lower_limit="-2.0" upper_limit="0.0"/>
                    <measurement group_id="O2" value="0.0" lower_limit="-1.0" upper_limit="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Resting Heart Rate</title>
        <description>Change in heart rate between Week 12 and Baseline</description>
        <time_frame>Baseline to 12 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Smartphone Text Messaging</title>
            <description>Group receives personalized, health coaching via &quot;smart&quot; text messages.</description>
          </group>
          <group group_id="O2">
            <title>No Smartphone Text Messaging</title>
            <description>Group does not receive personalized, health coaching via &quot;smart&quot; text messages.</description>
          </group>
        </group_list>
        <measure>
          <title>Resting Heart Rate</title>
          <description>Change in heart rate between Week 12 and Baseline</description>
          <units>beats per minute</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="-7" upper_limit="4"/>
                    <measurement group_id="O2" value="0" lower_limit="-7" upper_limit="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Total Lean Mass</title>
        <description>Change from baseline lean mass at week 12.</description>
        <time_frame>Baseline to 12 weeks</time_frame>
        <population>Only 17 participants in the Smartphone Text Messaging arm were analyzed due to research shut downs during COVID. Any assessments requiring an in-person visit were not completed for one participant.</population>
        <group_list>
          <group group_id="O1">
            <title>Smartphone Text Messaging</title>
            <description>Group receives personalized, health coaching via &quot;smart&quot; text messages.</description>
          </group>
          <group group_id="O2">
            <title>No Smartphone Text Messaging</title>
            <description>Group does not receive personalized, health coaching via &quot;smart&quot; text messages.</description>
          </group>
        </group_list>
        <measure>
          <title>Total Lean Mass</title>
          <description>Change from baseline lean mass at week 12.</description>
          <population>Only 17 participants in the Smartphone Text Messaging arm were analyzed due to research shut downs during COVID. Any assessments requiring an in-person visit were not completed for one participant.</population>
          <units>kilograms</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1" lower_limit="-1.1" upper_limit="1.2"/>
                    <measurement group_id="O2" value="0.0" lower_limit="-0.6" upper_limit="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Insulin Resistance</title>
        <description>Insulin resistance measured by the Homeostatic Model Assessment for Insulin Resistance insulin resistance score (HOMA-IR) utilizing the formula: fasting plasma glucose (mmol/l) times fasting serum insulin (mU/l) divided by 22.5. Low HOMA-IR values indicate high insulin sensitivity, whereas high HOMA-IR values indicate low insulin sensitivity (insulin resistance).</description>
        <time_frame>Baseline to 12 weeks</time_frame>
        <population>Only 17 participants in the Smartphone Text Messaging arm were analyzed due to research shut downs during COVID. Any assessments requiring an in-person visit were not completed for one participant.</population>
        <group_list>
          <group group_id="O1">
            <title>Smartphone Text Messaging</title>
            <description>Group receives personalized, health coaching via &quot;smart&quot; text messages.</description>
          </group>
          <group group_id="O2">
            <title>No Smartphone Text Messaging</title>
            <description>Group does not receive personalized, health coaching via &quot;smart&quot; text messages.</description>
          </group>
        </group_list>
        <measure>
          <title>Insulin Resistance</title>
          <description>Insulin resistance measured by the Homeostatic Model Assessment for Insulin Resistance insulin resistance score (HOMA-IR) utilizing the formula: fasting plasma glucose (mmol/l) times fasting serum insulin (mU/l) divided by 22.5. Low HOMA-IR values indicate high insulin sensitivity, whereas high HOMA-IR values indicate low insulin sensitivity (insulin resistance).</description>
          <population>Only 17 participants in the Smartphone Text Messaging arm were analyzed due to research shut downs during COVID. Any assessments requiring an in-person visit were not completed for one participant.</population>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.3" lower_limit="-0.2" upper_limit="0.8"/>
                    <measurement group_id="O2" value="0.0" lower_limit="-0.6" upper_limit="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>BNP</title>
        <description>Change from baseline B-type natriuretic peptide level at week 12.</description>
        <time_frame>Baseline to 12 weeks</time_frame>
        <population>Only 17 participants in the Smartphone Text Messaging arm were analyzed due to research shut downs during COVID. Any assessments requiring an in-person visit were not completed for one participant.</population>
        <group_list>
          <group group_id="O1">
            <title>Smartphone Text Messaging</title>
            <description>Group receives personalized, health coaching via &quot;smart&quot; text messages.</description>
          </group>
          <group group_id="O2">
            <title>No Smartphone Text Messaging</title>
            <description>Group does not receive personalized, health coaching via &quot;smart&quot; text messages.</description>
          </group>
        </group_list>
        <measure>
          <title>BNP</title>
          <description>Change from baseline B-type natriuretic peptide level at week 12.</description>
          <population>Only 17 participants in the Smartphone Text Messaging arm were analyzed due to research shut downs during COVID. Any assessments requiring an in-person visit were not completed for one participant.</population>
          <units>pg/mL</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2" lower_limit="-13" upper_limit="1"/>
                    <measurement group_id="O2" value="7" lower_limit="-14" upper_limit="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline on the SF-36 Physical Component Summary (PCS) Score</title>
        <description>SF-36 consists of 36 questions measuring 8 health domains: physical functioning, bodily pain, role limitations due to physical problems, role limitations due to emotional problems, general health perceptions, mental health, social function, and vitality. The patient's responses are solicited using Likert scales that vary in length, with 3-6 response options per item. The SF-36 can be scored into the 8 health domains named above and two overall summary scores: physical component summary (PCS) and mental component summary (MCS) scores. The domain and summary scores range from 0 to 100; higher scores indicate better levels of function and/or better health</description>
        <time_frame>Baseline to 12 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Smartphone Text Messaging</title>
            <description>Group receives personalized, health coaching via &quot;smart&quot; text messages.</description>
          </group>
          <group group_id="O2">
            <title>No Smartphone Text Messaging</title>
            <description>Group does not receive personalized, health coaching via &quot;smart&quot; text messages.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline on the SF-36 Physical Component Summary (PCS) Score</title>
          <description>SF-36 consists of 36 questions measuring 8 health domains: physical functioning, bodily pain, role limitations due to physical problems, role limitations due to emotional problems, general health perceptions, mental health, social function, and vitality. The patient's responses are solicited using Likert scales that vary in length, with 3-6 response options per item. The SF-36 can be scored into the 8 health domains named above and two overall summary scores: physical component summary (PCS) and mental component summary (MCS) scores. The domain and summary scores range from 0 to 100; higher scores indicate better levels of function and/or better health</description>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.8" lower_limit="-3.6" upper_limit="1.5"/>
                    <measurement group_id="O2" value="-0.4" lower_limit="-3.3" upper_limit="3.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Minutes of Moderate-vigorous Activity</title>
        <description>Change in minutes between Week 12 and Baseline</description>
        <time_frame>Baseline to 12 Weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Smartphone Text Messaging</title>
            <description>Group receives personalized, health coaching via &quot;smart&quot; text messages.</description>
          </group>
          <group group_id="O2">
            <title>No Smartphone Text Messaging</title>
            <description>Group does not receive personalized, health coaching via &quot;smart&quot; text messages.</description>
          </group>
        </group_list>
        <measure>
          <title>Minutes of Moderate-vigorous Activity</title>
          <description>Change in minutes between Week 12 and Baseline</description>
          <units>minutes</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.6" lower_limit="-5.1" upper_limit="16.1"/>
                    <measurement group_id="O2" value="-0.6" lower_limit="-4.5" upper_limit="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Visceral Fat Volume</title>
        <description>Change in fat volume between Week 12 and Baseline</description>
        <time_frame>Baseline to Week 12</time_frame>
        <population>Only 17 participants in the Smartphone Text Messaging arm were analyzed due to research shut downs during COVID. Any assessments requiring an in-person visit were not completed for one participant.</population>
        <group_list>
          <group group_id="O1">
            <title>Smartphone Text Messaging</title>
            <description>Group receives personalized, health coaching via &quot;smart&quot; text messages.</description>
          </group>
          <group group_id="O2">
            <title>No Smartphone Text Messaging</title>
            <description>Group does not receive personalized, health coaching via &quot;smart&quot; text messages.</description>
          </group>
        </group_list>
        <measure>
          <title>Visceral Fat Volume</title>
          <description>Change in fat volume between Week 12 and Baseline</description>
          <population>Only 17 participants in the Smartphone Text Messaging arm were analyzed due to research shut downs during COVID. Any assessments requiring an in-person visit were not completed for one participant.</population>
          <units>mL</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-67" lower_limit="-432" upper_limit="0.0"/>
                    <measurement group_id="O2" value="21" lower_limit="-84" upper_limit="177"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse Event data collected for 12 weeks from each participant</time_frame>
      <desc>Definitions of an adverse event and/or serious adverse event, used to collect adverse event information, is in line with clinicaltrials.gov.</desc>
      <group_list>
        <group group_id="E1">
          <title>Smartphone Text Messaging</title>
          <description>Group receives personalized, health coaching via &quot;smart&quot; text messages.&#xD;
Smartphone Text Messaging: A HIPPA compliant text messaging platform is linked to the Fitbit Application Program Interface. Real time activity data will be transmitted from the subject's smartphone to our mHealth platform via cellular network. Subjects will receive 3 texts/day in sync with their preferred morning, lunch, and evening leisure schedule (defined at enrollment). These texts will use personal, disease-specific, and provider information to deliver 2 types of messages customized to the current step count and sent in equal proportion. Messages are designed to facilitate self-awareness, reinforce step targets, and link physical activity with a reward or memorable cue.&#xD;
Fitbit Charge HR: The Fitbit Charge HR tri-axial accelerometer will be used to continuously gather data on physical activity, heart rate, and sleep. This device provides feedback in units of activity (steps, stairs climbed, activity time, and exercise time) and heart rate (per second when active, per 5 seconds when inactive). It has been validated against research devices in free-living conditions and is relatively inexpensive.</description>
        </group>
        <group group_id="E2">
          <title>No Smartphone Text Messaging</title>
          <description>Group does not receive personalized, health coaching via &quot;smart&quot; text messages.&#xD;
Fitbit Charge HR: The Fitbit Charge HR tri-axial accelerometer will be used to continuously gather data on physical activity, heart rate, and sleep. This device provides feedback in units of activity (steps, stairs climbed, activity time, and exercise time) and heart rate (per second when active, per 5 seconds when inactive). It has been validated against research devices in free-living conditions and is relatively inexpensive.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Hypertensive urgency</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="22"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Medication escalation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_at_risk="22"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="22"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Chest Pain</sub_title>
                <counts group_id="E1" events="7" subjects_affected="4" subjects_at_risk="20"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="22"/>
              </event>
              <event>
                <sub_title>Edema</sub_title>
                <counts group_id="E1" events="5" subjects_affected="2" subjects_at_risk="20"/>
                <counts group_id="E2" events="12" subjects_affected="4" subjects_at_risk="22"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="20"/>
                <counts group_id="E2" events="7" subjects_affected="4" subjects_at_risk="22"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Dyspnea</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="22"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Evan L. Brittain</name_or_title>
      <organization>Vanderbilt University Medical Center</organization>
      <phone>(615) 322-4382</phone>
      <email>Evan.brittain@vumc.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

